Skjørringe T - Search Results

1

Macromolecular drug transport into the brain using targeted therapy.

Lichota J, Skjørringe T, Thomsen LB, Moos T. Lichota J, et al. Among authors: skjorringe t. J Neurochem. 2010 Apr;113(1):1-13. doi: 10.1111/j.1471-4159.2009.06544.x. Epub 2009 Dec 14. J Neurochem. 2010. PMID: 20015155 Free article. Review.

2

Iron trafficking inside the brain.

Moos T, Rosengren Nielsen T, Skjørringe T, Morgan EH. Moos T, et al. Among authors: skjorringe t. J Neurochem. 2007 Dec;103(5):1730-40. doi: 10.1111/j.1471-4159.2007.04976.x. Epub 2007 Oct 22. J Neurochem. 2007. PMID: 17953660 Free article. Review.

3

Expression of Iron-Related Proteins at the Neurovascular Unit Supports Reduction and Reoxidation of Iron for Transport Through the Blood-Brain Barrier.

Burkhart A, Skjørringe T, Johnsen KB, Siupka P, Thomsen LB, Nielsen MS, Thomsen LL, Moos T. Burkhart A, et al. Among authors: skjorringe t. Mol Neurobiol. 2016 Dec;53(10):7237-7253. doi: 10.1007/s12035-015-9582-7. Epub 2015 Dec 21. Mol Neurobiol. 2016. PMID: 26687231

4

Impairment of interrelated iron- and copper homeostatic mechanisms in brain contributes to the pathogenesis of neurodegenerative disorders.

Skjørringe T, Møller LB, Moos T. Skjørringe T, et al. Front Pharmacol. 2012 Sep 25;3:169. doi: 10.3389/fphar.2012.00169. eCollection 2012. Front Pharmacol. 2012. PMID: 23055972 Free PMC article.

5

Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology.

Skjørringe T, Burkhart A, Johnsen KB, Moos T. Skjørringe T, et al. Front Mol Neurosci. 2015 Jun 8;8:19. doi: 10.3389/fnmol.2015.00019. eCollection 2015. Front Mol Neurosci. 2015. PMID: 26106291 Free PMC article. Review.

6

Iron deficiency and iron treatment in the fetal developing brain - a pilot study introducing an experimental rat model.

Moos T, Skjørringe T, Thomsen LL. Moos T, et al. Among authors: skjorringe t. Reprod Health. 2018 Jun 22;15(Suppl 1):93. doi: 10.1186/s12978-018-0537-0. Reprod Health. 2018. PMID: 29945643 Free PMC article.

7

Splice site mutations in the ATP7A gene.

Skjørringe T, Tümer Z, Møller LB. Skjørringe T, et al. PLoS One. 2011 Apr 11;6(4):e18599. doi: 10.1371/journal.pone.0018599. PLoS One. 2011. PMID: 21494555 Free PMC article.

8

Crystal structure of a copper-transporting PIB-type ATPase.

Gourdon P, Liu XY, Skjørringe T, Morth JP, Møller LB, Pedersen BP, Nissen P. Gourdon P, et al. Among authors: skjorringe t. Nature. 2011 Jun 29;475(7354):59-64. doi: 10.1038/nature10191. Nature. 2011. PMID: 21716286

9

Occipital horn syndrome and classical Menkes Syndrome caused by deep intronic mutations, leading to the activation of ATP7A pseudo-exon.

Yasmeen S, Lund K, De Paepe A, De Bie S, Heiberg A, Silva J, Martins M, Skjørringe T, Møller LB. Yasmeen S, et al. Among authors: skjorringe t. Eur J Hum Genet. 2014 Apr;22(4):517-21. doi: 10.1038/ejhg.2013.191. Epub 2013 Sep 4. Eur J Hum Genet. 2014. PMID: 24002164 Free PMC article.

10

A silent nucleotide substitution in the ATP7A gene in a child with Menkes disease.

Møller LB, Rea G, Yasmeen S, Skjørringe T, Thorborg SS, Morrison PJ, Donnelly DE. Møller LB, et al. Among authors: skjorringe t. Mol Genet Metab. 2013 Dec;110(4):490-2. doi: 10.1016/j.ymgme.2013.09.012. Epub 2013 Sep 24. Mol Genet Metab. 2013. PMID: 24100245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page